6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: Possible interactions with subcortical dopamine

Journal of Neuroscience

Volumn 14, Issue 5 I, 1994, Pages 2531-2544

  Roberts, A C ^a   De Salvia, M A ^c   Wilkinson, L S ^a   Collins, P ^a   Muir, J L ^a   Everitt, B J ^b   Robbins, T W ^a  

^a University of Cambridge   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

attentional set; dopamine; Parkinson's disease; prefrontal cortex; schizophrenia; set shifting; spatial delayed response; striatum

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CORPUS STRIATUM; FEMALE; MALE; MONKEY; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; TASK PERFORMANCE;

EID: 0028255978     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.14-05-02531.1994     Document Type: Article

References (64)

1. Albert M, Feldman RG, Willis AL (1974) The subcortical dementia of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37: 121-130.
2. Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271.
3. Alexander GE, De Long MF, Strick PL (1986) Parallel organisation of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381.
4. Amsten AFT, Contant TA (1992) Alpha-2-adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology (Berlin) 108:159-169.
5. Arnsten AFT, Goldman-Rakic (1985) Alpha-2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230:1273-1276.
6. Arnt J, Christensen AV, Hyttel J (1985) Pharmacology in vivo of the Phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine. noradrenaline and 5-hydroxytryptamine uptake in rat brain. Naunyn Schmiedebergs Arch Pharmacol 329:101-107.
7. Baker AG, Mackintosh NJ (1977) Excitatory and inhibitory conditioning following uncorrelated presentations of CS and UCS. Anim Learn Behav 5:315-319.
8. Berger HGC, Van Hoof JJM, Van Spaendonck KPM, Horstink MWI, Van Den Bercken JHL, Jaspers RJ, Cools AR (1989) Haloperidol and cognitive shifting. Neuropsychologia 27:629-639.
9. Berman KF, Weinberger DR (1990) The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: in vivo physiological correlates of cognitive deficits. Prog Brain Res 85:521-536.
10. Bernheimer H, Birkmayer W, Hornykiewicz O (1973) Braindopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20: 415-455.
11. Brodmann K (1909) Vergleichende lokalisationslehre der großhimrinde in ihren prinzipierdargestellt aufgrund des zellenbaues. Leipzig: Barth.
12. Brozoski TJ, Brown R, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science 205:929-931.
13. Canavan AGM, Passingham RE, Marsden CD, Quinn N, Wyke M, Polkey CE (1989) The performance on learning tasks of patients in the early stages of Parkinson's disease. Neuropsychologia 27:141-156.
14. Devauges V, Sara SJ (1990) Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav Brain Res 39:19-28.
15. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW (1989) Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 27:1329-1343.
16. Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y (1983) A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 288:213-218.
17. Durlach PJ, Mackintosh NJ (1986) Transfer of serial reversal learning in the pigeon. Q J Exp Psychol 38B:81-95.
18. Eimas PD (1966) Effects of overtraining and age on intradimensional and extradimensional shifts in children. J Exp Child Psychol 3:348-355.
19. Everitt BJ, Robbins TW, Selden NRW (1992) Functions of the locus coeruleus noradrenergic system: a neurobiological and behavioural synthesis. In: The pharmacology of noradrenaline in the CNS (Heal D, Marsden C, eds), pp 349-378. Oxford: Oxford UP.
20. Gerfen CR (1992) D1 and D2 dopamine receptor regulation of striatonigral and striatopallidal neurons. In: Seminars in the neurosciences, Milestones in dopamine research (Robbins TW, ed), pp 149-160. London: Academic.
21. Glowinski H, Cheramy A, Romo R, Barbeito L (1988) Presynaptic regulation of dopaminergic transmission in the striatum. Cell Mol Neurobiol 8:7-17.
22. Goldman-Rakic PS (1992) Dopamine-mediated mechanisms of the prefrontal cortex. In: Seminars in the neurosciences, Milestones in dopamine research (Robbins TW, ed), pp 109-118. London: Academic.
23. Grafman J, Litvan I, Gomez C, Chase TN (1990) Frontal lobe function in progressive supranuclear palsy. Arch Neurol 47:553-558.
24. Gross CG, Weiskrantz L (1962) Evidence for dissociation of impairment on auditory discrimination and delayed response following lateral frontal lesions in monkeys. Exp Neurol 5:453-476.
25. Herve D. Trovero F, Blanc G, Thierry AM, Glowinski J, Tassin J-P (1991) Non-dopaminergic prefrontocortical efferent fibers modulate D1 receptor denervation supersensitivity in specific regions of rat striatum. J Neurosci 9:3699-3708.
26. Hyttel J (1982) Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277-295.
27. Jaskiw GE, Weinberger DR (1992) Dopamine and schizophrenia - a cortically corrective perspective. In: Seminars in the neurosciences, Milestones in dopamine research (Robbins TW, ed), pp 179-188. London: Academic.
28. Jaskiw GE, Weinberger DR, Crawley JN (1991) Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in micro-dialysate from the caudate nucleus. Biol Psychiatry 29:703-706.
29. Javoy-Agid F (1987) Biochemical neuropathology of Parkinson disease. Adv Neurol 40:189-198.
30. Jones B, Mishkin M (1972) Limbic lesions and the problem of stimulus-reinforcement associations. Exp Neurol 36:362-377.
31. Kalivas PW, Duffy P, Barrow J (1989) Regulation of the mesocorti-colimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251:378-387.
32. Keefe KA. Zigmond MJ, Abercrombie ED (1992) Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutaminergic input. Neuroscience 47:325-332.
33. Leenders KL (1993) Mental dysfunction in patients with Parkinson's disease: PET investigations. In: Mental dysfunction in Parkinson's disease (Walters EC, Scheltens P, eds). pp 133-140. Amsterdam: Vrije Universiteit.
34. Lees AJ. Smith E (1983) Cognitive deficits in the early stages of Parkinson's disease. Brain 106:257-270.
35. Louilot A, Le Moal M, Simon H (1989) Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study. Neuroscience 29:45-56.
36. Lueck CJ, Tanyeri S, Crawford TJ, Henderson L, Kennard C (1990) Antisaccades and remembered saccades in Parkinson's disease. J Neurol Neurosurg Psychiatry 52:284-288.
37. Mason ST, Lin D (1980) Dorsal noradrenergic bundle and selective attention in the rat. J Comp Physiol Psychol 94:819-832.
38. Milner B (1963) Effects of different brain lesions on card sorting. Arch Neurol 9:100-110.
39. Milner B (1982) Some cognitive effects of frontal lobe lesions in man. Philos Trans R Soc Lond [Biol] 286:211-226.
40. Mishkin M (1957) Effects of small frontal lesions on delayed alternation in monkeys. J Neurophysiol 20:615-622.
41. Mishkin M (1964) Perseveration of central sets after frontal lesions in man. In: The frontal granular cortex and behavior (Warren JM, Akert K, eds), pp 219-294. New York: McGraw-Hill.
42. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW (1991) Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excision, temporal lobe excision or amygdalo-hippocampectomy in man. Neuropsychologia 29:993-1006.
43. Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP. Lange KW, Robbins TW (1992) Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115:1727-1751.
44. Owen AM, Roberts AC, Hodges JR, Summers BA, Polkey CE, Robbins TW (1993) Contrasting mechanisms of impaired attentional setshifting in patients with frontal lobe damage or Parkinson's disease. Brain 116:1159-1175.
45. Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairburn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48: 413-421.
46. Pillon B, Dubois B, Lhermitte F, Agid Y (1986) Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease and Alzheimer's disease. Neurology 36:1179-1185.
47. Pisa M, Fibiger HC (1983) Intact selective attention in rats with lesions of the dorsal noradrenergic bundle. Behav Neurosci 97:519-529.
48. Pycock CJ, Kerwin RW, Carter CJ (1980) Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286:74-77.
49. Robbins TW (1977) A critique of the methods available for the measurement of spontaneous motor activity. In: The handbook of psychopharmacology, Vol 7 (Iversen LL, Iversen SD, Snyder SH eds), pp 37-82. New York: Plenum.
50. Robbins TW, Brown VJ (1990) The role of the striatum in the mental chronometry of action: a theoretical review. Rev Neurosci 2:181-213.
51. Roberts AC, Robbins TW, Everitt BJ (1988) The effects of intradimensional and extradimensional shifts on visual discrimination learning in humans and non-human primates. Q J Exp Psychol 40:321-341.
52. Roberts AC, Robbins TW, Everitt BJ, Jones GH, Sirkia TE. Wilkinson J, Page K (1990) The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets. Neuroscience 34:311-329.
53. Roberts AC, Robbins TW, Everitt BJ, Muir JL (1992) A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in the marmoset. Neuroscience 47:251-264.
54. Rosin DL, Clark WA, Goldstein M, Roth RH, Deutch AY (1992) Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience 48:831-839.
55. Ruggeri M, Zoli M, Grimaldi R, Ungerstedt U, Eliasson A, Agnati LF, Fuxe K (1990) Aspects of neural plasticity in the central nervous system-III. Methodological studies on the microdialysis technique. Neurochem Int 16:427-435.
56. 1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251:947-950.
57. Scatton B, Javoy-Agid F, Rouqier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275:321-328.
58. Schneider JS, Kovelowski CJ (1990) Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res 519:122-128.
59. Shepp BE, Schrier AM (1969) Consecutive intradimensional and extradimensional shifts in monkeys. J Comp Physiol Psychol 67:199-203.
60. Slamecka NJ (1968) A methodological analysis of shift paradigms in human discrimination learning. Psychol Bull 69:423-428.
61. Stephan H, Baron G, Schwerdtfeger WK (1980) The brain of the common marmoset (Callithrix jacchus): a stereotaxic atlas. Berlin: Springer.
62. Stuss DT, Benson DF, Kaplan EF, Weir WS, Malva CD (1981) Leucotomised and nonleucotomised schizophrenics: comparison of tests of attention. Biol Psychiatry 16:1085-1100.
63. Taylor AE, Saint-Cyr JA, Lang AE (1986) Frontal lobe dysfunction in Parkinson's disease. Brain 109:845-883.
64. Williams GV, Millar J (1990) Differential actions of endogenous and iontophoretic dopamine in rat striatum. Eur J Neurosci 2:658-661.